Sponsor & Exhibitor Profiles
Ascendis Pharma
[Founded in 2007], Ascendis Pharma is applying its innovative TransCon™ technology platform to build a leading, fully integrated biopharma company focused on making a meaningful difference in patients’ lives. Guided by our core values of patients, science and passion, we use our TransCon technologies to fulfill our mission of developing new and potentially best-in-class therapies that address unmet medical needs. Ascendis is headquartered in Copenhagen, Denmark, and has additional facilities in Europe and the United States. Please visit www.ascendispharma.com to learn more.
Biospace Lab
website: www.biospacelab.com
Biospace Lab provides innovative real-time preclinical imaging systems, including bioluminescence, NIR I, NIR II fluorescence and autoradiography, to help researchers advance their biological research. Founded in 1989 by Georges Charpak, Biospace Lab revolutionised the field by introducing the first real-time digital autoradiography system, for which Charpak was awarded the Nobel Prize. Since then, the company has continued to innovate, forging close links with scientific research to be at the forefront of optical imaging for preclinical studies. Based near Paris, Biospace Lab markets its cutting-edge technologies to prestigious pharmaceutical companies and academic institutions worldwide.
Bruker Biospin GmbH
Bruker’s differentiated high-value life science research and diagnostics solutions enable scientists to make breakthrough discoveries and develop new applications that improve the quality of human life.
Bruker’s portfolio of 3D X-ray microCT systems offers turnkey solutions for non-destructive, high resolution 3D imaging of small laboratory animals and a wide variety biological samples. This includes mineralized and soft tissues, tumors, plants and insects, as well as archeological and paleontological research fields.
CompagOs
CompagOs, a Swiss startup from ETH Zürich, develops diagnostic and research tools utilizing 3D-bioprinted, mineralized, and multicellular in vitro bone models.
EuRR-Bone – EuRRECa
The European Registries for Rare Bone and Mineral Conditions (EuRR-Bone) and European Registries for Rare Endocrine Conditions (EuRRECa) aim to support the needs of the endocrine and bone community by facilitating the collaboration between patients, health care professionals and researchers across Europe and beyond. EuRR-Bone/EuRRECa offers two open access platforms to capture rare conditions covered within the reference networks ERN BOND and Endo-ERN. The registries are open to all professionals involved in the care of these conditions
Gedeon Richter Plc
Headquartered in Hungary, Gedeon Richter Plc. is an innovation-driven specialty pharmaceutical company. Innovation and the research of original drug molecules have been key elements in the Company’s strategy since its foundation in 1901. Several years ago, Gedeon Richter identified the growing importance of biological drugs over the medium to long-term and took the strategic decision to enter this novel area of medicine in 2006. When selecting candidate products Richter proceeded very carefully, focusing on certain therapeutic areas, notably rheumatology, immunology and osteoporosis. Our goal is to provide cutting-edge approaches that address the unique needs of patients, contributing to a healthier and more fulfilling life.
Inozyme Pharma, inc.
Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases driven by pathologic mineralization and intimal proliferation which impact the vasculature, soft tissue and skeleton. We are initially focused on developing an enzyme therapy to treat ENPP1 and ABCC6 Deficiencies, two rare genetic diseases associated with significant morbidity, mortality, and unmet medical need.
International Federation of Musculoskeletal Research Societies (IFMRS)
Website: www.ifmrs.org
We are a global, non-profit federation of musculoskeletal (MSK) research societies, covering all forms of MSK conditions and all aspects of research.
Our 27 member societies come from all parts of the world, and include majors organizations such as the ECTS and ASBMR as well as many from low- and middle-income countries.
We work with our members and partners to improve the prevention and treatment of all forms of MSK conditions, amplifying the voice of our members, developing shared resources and spearheading joint initiatives.
Please visit our Knowledge Network and sign up for our newsletter at www.ifmrs.org.
KUBTEC Scientific
KUBTEC Scientific is a minority woman-owned company founded in 2005, and headquartered in Connecticut, USA. We are a progressive research and technology organization dedicated to designing innovative and proprietary tools to accelerate your research. Our diverse range of products includes benchtop and free-standing digital cabinet X-ray systems for imaging and irradiation of small animals like rodents, fishes, etc. Other applications include agricultural and forestry sciences, forensics imaging and other industrial non-destructive applications developed for academic, government and industrial institutions. KUBTEC X-ray imaging systems reveal the finest details of your sample, small animal bones and tissues, allowing you to make observations that would otherwise be unfeasible. Our in-vivo cabinet X-ray systems can help collect powerful datasets for longitudinal studies and our optional anesthesia port makes continuous anesthesia easy.
Kyowa Kirin International Plc.
Kyowa Kirin strives to create and deliver novel medicines with life-changing value. As a Japan-based Specialty Pharmaceutical Company with a heritage of 70+ years, we apply cutting-edge science including an expertise in antibody research and engineering, to address the needs of patients and society across multiple therapeutic areas including Nephrology, Oncology, Immunology/Allergy and Neurology. Across our four regions – Japan, Asia Pacific, North America and EMEA/International – we focus on our purpose, to make people smile, and are united by our shared values of commitment to life, teamwork/Wa, innovation, and integrity.
You can learn more about the business of Kyowa Kirin at: https://international.kyowa-kirin.com/uk/
Osteosys
Website: https://osteosys.com/en/
Founded in 2000, Osteosys is a global leading brand of clinical Bone Mineral Densitometer (BMD). From 2020 onwards, Osteosys has been expanding its portfolio to various new fields including preclinical sectors by launching iNSiGHT, preclinical in-vivo DXA system for longitudinal analysis of bone and body composition. iNSiGHT is a fully shielded DXA cabinet body composition and BMD for lab animals. It offers fast scan(less than 20 sec), high resolution image, multiple ROIs with cone beam HFG and flat panel detector for ultimate precision an accuracy.
REVVITY
We are immensely excited to share with you that we are Revvity, a visionary partner in developing technologies and solutions across disease pathways to help solve the world’s greatest health challenges.
The meaning behind Revvity
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents our commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere. We provide health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure.
Your challenge is our call to action
We specialize in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Every day, our 11,000 employees worldwide collaborate to pioneer technologies, solutions, and services that help you, our customers, redefine the health of our world. With a robust global network and localized agility, we serve a diverse range of organizations from pharmaceutical and biotech, to clinical labs, academia, and governments.
Revvity exists to expand the boundaries of human potential through science. Together with our customers and partners we will bring our purpose to life.
Scanco Medical AG
Scanco Medical (www.scanco.ch), based in Zurich, Switzerland (since 1988) is the leading global provider of mCT and the HR-pQCT (XtremeCT) systems. Specimen scanners offer industry leading high-resolution and large specimen size capabilities and include a high-capacity automatic sample loading carousel enabling a high throughput workflow. All systems are bundled with easy to use and comprehensive software for image acquisition and analysis including Finite Element Analysis (optional), visualization and archiving running on Windows ® based workstations (except XtremeCT). Scanco also provides contract-based scanning and analysis services for academic and industrial groups. Contact us for a free and no-obligation demonstration.
Novotec Medical GmbH / Stratec Medizintechnik GmbH
Stratec Medizintechnik is the producer of pQCT-based bone densitometry scanners. Results are presented in real density units (g/cm³). Additionally, geometrical properties of bone can be analysed which allow the estimation of mechanical properties. The combined analysis of muscle and bone allows differentiation of disuse osteopenia from true osteoporosis.
The sister company Novotec Medical is manufacturer of Galileo vibration training devices for muscle stimulation and of Leonardo motion analysis systems (mechanography). The side alternating technology employs a natural movement similar to human gait. Improvement of muscle function, treatment of back pain and immobility are typical fields of application.
UCB Biopharma SRL
At UCB, we believe everyone deserves to live the best life that they can – as free as possible from the challenges of disease. We develop solutions across neurology, immunology, and other areas where our expertise, innovation, and ambition align with the needs of those who live with severe diseases.
We are curious and collaborative, driven to create valuable solutions and improve the health and wellbeing of our people, our communities and the planet. We seek out tools, technologies, and partners that help us respond to patient needs with purposeful innovations that make a truly meaningful impact.